Australia markets closed

Carisma Therapeutics, Inc. (CARM)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
1.4100+0.0400 (+2.92%)
At close: 04:00PM EDT
1.3700 -0.04 (-2.84%)
After hours: 07:38PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts4444
Avg. Estimate-0.3-0.26-1.26-1.24
Low estimate-0.43-0.42-1.79-2.07
High estimate-0.17-0.11-0.74-0.68
Year ago EPS-0.49-0.53-2.59-1.26
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts4443
Avg. Estimate3.92M4.3M15.52M9.6M
Low estimate3.4M3.4M13.6MN/A
High estimate5M5M18.4M15.2M
Year ago sales3.56M3.83M14.92M15.52M
Sales growth (year/est)10.10%12.40%4.00%-38.10%
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS-0.6-0.57-0.55-0.43
Actual EPS-0.49-0.53-0.52-0.46
Difference0.110.040.03-0.03
Surprise %18.30%7.00%5.50%-7.00%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate-0.3-0.26-1.26-1.24
7 days ago-0.29-0.26-1.2-1.23
30 days ago-0.33-0.28-1.29-1.29
60 days ago-0.51-0.51-2.13-1.87
90 days ago-0.51-0.51-2.13-1.87
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 days3333
Down last 7 daysN/AN/AN/AN/A
Down last 30 days1111
Growth estimatesCARMIndustrySector(s)S&P 500
Current qtr.38.80%N/AN/AN/A
Next qtr.50.90%N/AN/AN/A
Current year51.40%N/AN/AN/A
Next year1.60%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A